Roles of CCR10/CCL27-CCL28 axis in tumour development: mechanisms, diagnostic and therapeutic approaches, and perspectives
- PMID: 36155126
- DOI: 10.1017/erm.2022.28
Roles of CCR10/CCL27-CCL28 axis in tumour development: mechanisms, diagnostic and therapeutic approaches, and perspectives
Abstract
Cancer is now one of the major causes of death across the globe. The imbalance of cytokine and chemokine secretion has been reported to be involved in cancer development. Meanwhile, CC chemokines have received considerable interest in cancer research. CCR10, as the latest identified CC chemokine receptor (CCR), has been implicated in the recruitment and infiltration of immune cells, especially lymphocytes, into epithelia such as skin via ligation to two ligands, CCL27 and CCL28. Other than homoeostatic function, several mechanisms have been shown to dysregulate CCR10/CCL27-CCL28 expression in the tumour microenvironment. As such, these receptors and ligands mediate T-cell trafficking in the tumour microenvironment. Depending on the types of lymphocytes recruited, CCR10/CCL27-CCL28 interaction has been shown to play conflicting roles in cancer development. If they were T helper and cytotoxic T cells and natural killer cells, the role of this axis would be tumour-suppressive. In contrast, if CCR10/CCL27-CCL28 recruited regulatory T cells, cancer-associated fibroblasts or myeloid-derived suppressor cells, it would lead to tumour progression. In addition to the trafficking of lymphocytes and immune cells, CCR10 also leads to the migration of tumour cells or endothelial cells (called angiogenesis and lymphangiogenesis) to promote tumour metastasis. Furthermore, CCR10 signalling triggers tumour-promoting signalling such as PI3K/AKT and mitogen-activated protein kinase/extracellular signal-regulated kinase, resulting in tumour cell growth. Since CCR10/CCL27-CCL28 is dysregulated in the tumour tissues, it is suggested that analysis and measurement of them might predict tumour development. Finally, it is hoped using therapeutic approaches based on this axis might increase our knowledge to overcome tumour progression.
Keywords: CCL27; CCL28; CCR10; Cancer; chemokine.
Similar articles
-
CCL27/CCL28-CCR10 Chemokine Signaling Mediates Migration of Lymphatic Endothelial Cells.Cancer Res. 2019 Apr 1;79(7):1558-1572. doi: 10.1158/0008-5472.CAN-18-1858. Epub 2019 Feb 1. Cancer Res. 2019. PMID: 30709930
-
CCL28 production in HaCaT cells was mediated by different signal pathways from CCL27.Exp Dermatol. 2006 Feb;15(2):95-100. doi: 10.1111/j.1600-0625.2005.00390.x. Exp Dermatol. 2006. PMID: 16433680
-
[Role of the CCL28-CCR10 pathway in monocyte migration in rheumatoid arthritis].Beijing Da Xue Xue Bao Yi Xue Ban. 2022 Dec 18;54(6):1074-1078. doi: 10.19723/j.issn.1671-167X.2022.06.003. Beijing Da Xue Xue Bao Yi Xue Ban. 2022. PMID: 36533335 Free PMC article. Chinese.
-
CCR10 and its ligands in regulation of epithelial immunity and diseases.Protein Cell. 2012 Aug;3(8):571-80. doi: 10.1007/s13238-012-2927-3. Epub 2012 Jun 8. Protein Cell. 2012. PMID: 22684736 Free PMC article. Review.
-
CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands.Int J Mol Sci. 2020 Oct 15;21(20):7619. doi: 10.3390/ijms21207619. Int J Mol Sci. 2020. PMID: 33076281 Free PMC article. Review.
Cited by
-
Circulating levels of cytokines and risk of urologic cancers: a two-sample Mendelian randomization study.BMC Cancer. 2024 Oct 10;24(1):1261. doi: 10.1186/s12885-024-13016-9. BMC Cancer. 2024. PMID: 39390542 Free PMC article.
-
Mapping the causal associations of cytokines with sarcopenia and aging traits: Evidence from bidirectional Mendelian randomization.J Cachexia Sarcopenia Muscle. 2024 Jun;15(3):1121-1133. doi: 10.1002/jcsm.13456. Epub 2024 Mar 31. J Cachexia Sarcopenia Muscle. 2024. PMID: 38556722 Free PMC article.
-
CCL28 promotes progression of hepatocellular carcinoma through PDGFD-regulated MMP9 and VEGFA pathways.Discov Oncol. 2024 Jul 31;15(1):324. doi: 10.1007/s12672-024-01185-9. Discov Oncol. 2024. PMID: 39085670 Free PMC article.
-
New genetic and epigenetic insights into the chemokine system: the latest discoveries aiding progression toward precision medicine.Cell Mol Immunol. 2023 Jul;20(7):739-776. doi: 10.1038/s41423-023-01032-x. Epub 2023 May 17. Cell Mol Immunol. 2023. PMID: 37198402 Free PMC article. Review.
-
The mechanism of cytokine regulation of cancer occurrence and development in the tumor microenvironment and its application in cancer treatment: a narrative review.Transl Cancer Res. 2024 Oct 31;13(10):5649-5663. doi: 10.21037/tcr-24-679. Epub 2024 Oct 18. Transl Cancer Res. 2024. PMID: 39525000 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials